Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Anders Ljunggren will support Stuart Gander, who as previously communicated, will take over as Group CEO as of 1 March 2024. Anders Ljunggren will be based in Uppsala and thus work as a strong bridge between Uppsala and the US where Stuart Gander is initially based.
Anders Ljunggren has extensive experience from the healthcare industry, with a focus on diagnostics and medical technology. In recent years, he has led the project organization at Q-linea and has previously worked with, among others, Tobii and GE Healthcare. Anders has a deep knowledge of Q-linea's various departments and is a member of the company's management team.
"I am very much looking forward to starting to work with Stuart and continuing to work with the management team in my new role, with a focus on helping the organization develop to become even better at delivering its projects and commitments according to our strategic plan. Q-linea consists of a team of highly competent people and the work holds a high technical level. It is an environment that I have worked in for many years and feel comfortable in. I am grateful for the trust that the board has given me and am humbled by the challenge that the role of Managing Director entails", says Anders Ljunggren, incoming Managing Director of Q-linea AB.
"I welcome Anders in his new role as leader of Q-linea's Swedish organization. Together with Stuart and others in the management group, they will form a strong team for Q-linea's continued commercialization and development", says Erika Kjellberg Eriksson, Chairman of the board of Q-linea.